Sigyn Therapeutics (SIGY) Capital Expenditures (2016 - 2022)
Sigyn Therapeutics (SIGY) posted Capital Expenditures of $1.0 for Q3 2022, down 99.99% sequentially from $9059.0 in Q4 2021, and down 99.99% YoY from $17334.0 in Q3 2021.
Sigyn Therapeutics (SIGY) Capital Expenditures (2016 - 2022) Analysis & Trends
Sigyn Therapeutics has reported Capital Expenditures for 5 years, with the latest figure at $1.0 in Q3 2022.
- Quarterly Capital Expenditures fell 99.99% year-over-year to $1.0 in Q3 2022, while the trailing twelve-month figure through Dec 2022 was $26394.0 (down 9.81% YoY) and the FY2022 annual result came in at $860.0, down 97.06% from the prior year.
- Capital Expenditures slipped to $1.0 in Q3 2022 per SIGY's latest filing, from $9059.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $17334.0 in Q3 2021 and troughed at $1.0 in Q3 2022.
- A 3-year average of $6271.0 and a median of $2871.0 in 2021 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 99.99% in 2022, down 99.99% in 2022.
- Over 3 years, Capital Expenditures stood at $2090.0 in 2018, then soared by 333.44% to $9059.0 in 2021, then sank by 99.99% to $1.0 in 2022.
- According to Business Quant data, Capital Expenditures over the past three periods registered $1.0, $9059.0, and $17334.0 for Q3 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.00 |
| Sep 30, 2022 | 1.00 |
| Dec 31, 2021 | 9,059.00 |
| Dec 31, 2021 | 9,059.00 |
| Sep 30, 2021 | 17,334.00 |
| Sep 30, 2021 | 17,334.00 |
| Mar 31, 2021 | 2,871.00 |
| Mar 31, 2021 | 2,871.00 |
| Dec 31, 2018 | 2,090.00 |
| Dec 31, 2018 | 2,090.00 |
| Jun 30, 2017 | 470.00 |
| Jun 30, 2017 | 470.00 |
| Mar 31, 2017 | 470.00 |
| Mar 31, 2017 | 470.00 |
| Mar 31, 2016 | 3,283.00 |
| Mar 31, 2016 | 3,283.00 |